A Real-World Evidence-Based Study of Long-Term Tyrosine Kinase Inhibitors Dose Reduction or Discontinuation in Patients with Chronic Myeloid Leukaemia

por Martín Roldán, Alicia, Sánchez Suárez, María Del Mar, Alarcón-Payer, Carolina, Jiménez Morales, Alberto, Puerta Puerta, José Manuel
Publicado 2023

Impact of Genetic Polymorphisms and Biomarkers on the Effectiveness and Toxicity of Treatment of Chronic Myeloid Leukemia and Acute Myeloid Leukemia

por Alarcón-Payer, Carolina, Sánchez Suárez, María Del Mar, Martín Roldán, Alicia, Puerta Puerta, José Manuel, Jiménez Morales, Alberto
Publicado 2022

Arterial hypertension assessment in a population with chronic myeloid leukemia

por Roa-Chamorro, Ricardo, Jaén-Águila, Fernando, Puerta-Puerta, José Manuel, Torres-Quintero, Lucía, González-Bustos, Pablo, Mediavilla-García, Juan Diego
Publicado 2021

Concentration of low-density lipoproteins (LDL) is significantly reduced after nilotinib discontinuation

por Roa-Chamorro, Ricardo, Puerta-Puerta, José Manuel, Torres-Quintero, Lucía, Jaén-Águila, Fernando, González-Bustos, Pablo, Rodríguez-Gil, Miguel Ángel, Mediavilla-García, Juan Diego
Publicado 2023